Issue: Volume XXX, No. 1 - January 3, 2023

Eight Macro Trends for Clinical Labs Will Shape Diagnostic Services in 2023 and Beyond

The Dark Report’s “Eight Macro Trends for Clinical Labs in 2023” delivers the insights that lab administrators and pathologists will want to study as they formulate their future business strategies. These include staffing shortages, factors threatening the stability of labs and hospitals, digital pathology’s future, and the demand for pathologists. Also in our list of …

Eight Macro Trends for Clinical Labs Will Shape Diagnostic Services in 2023 and Beyond Read More »

PAMA Cuts Have Simply Been Kicked Down the Road

PAYMENT RATE CUTS FOR CLINICAL LABORATORY TESTS, called for under the Protecting Access to Medicare Act of 2014 (PAMA), have been avoided temporarily—again.  A down-to-the-wire bill in Congress to keep the federal government funded into the new year included a provision to delay PAMA cuts to the Clinical Laboratory Fee Schedule (CLFS) for 2023. This …

PAMA Cuts Have Simply Been Kicked Down the Road Read More »

Eight Macro Trends for Clinical Labs in 2023

CEO SUMMARY: Laboratory administrators and pathologists will want to carefully study eight important trends that will guide their business strategies in 2023. Many of these macro trends center on financial and operational difficulties and ways to steer around these obstacles. Another broad theme is how established technology is poised in the new year to tackle …

Eight Macro Trends for Clinical Labs in 2023 Read More »

How Consumers Shape Modern Laboratory Outreach

CEO SUMMARY: Each of the different generations engaging with clinical laboratory outreach programs brings their own set of expectations to a blood draw. Innovative hospital lab outreach programs should serve these differences by offering multiple options to provide appointment convenience, testing price transparency, and encouraging customer feedback. CATERING TO THE CURRENT DEMANDS OF HEALTHCARE CONSUMERS, …

How Consumers Shape Modern Laboratory Outreach Read More »

Congress Averts PAMA Cuts to Lab Test Rates for 2023

CONGRESS ENACTED LEGISLATION LAST MONTH that suspends implementation of the next round of price cuts to the Medicare Part B Clinical Laboratory Fee Schedule (CLFS) that was scheduled to take effect on Jan. 1. This is a welcome development for the medical laboratory industry.  A two-paragraph inclusion in a 4,000- page, year-end government spending bill …

Congress Averts PAMA Cuts to Lab Test Rates for 2023 Read More »

Siemens Healthineers Plans to Streamline Product Offerings

DURING A 15-MONTH STRETCH FROM 2006-2007, Siemens Healthineers spent $14 billion to acquire three competing companies and their various technologies.  Today, Siemens is preparing to sunset as many as half of its legacy instruments and assays, which is likely the endgame of its purchasing spree long ago. As a result, clinical laboratory and pathologist customers …

Siemens Healthineers Plans to Streamline Product Offerings Read More »

January 3, 2023, Intelligence: Late-Breaking Lab News

At the moment, it appears that the controversial Verifying Accurate Leading-edge IVCT Development (VALID) Act will have a hard time passing in Congress. The bill, which is intended to shift regulation of laboratory-developed tests (LDTs) to the federal Food and Drug Administration, fell to the wayside during year-end spending negotiations in Congress. Despite a strong …

January 3, 2023, Intelligence: Late-Breaking Lab News Read More »

;